Florent Peron

Florent Peron

Auto-generated profile, based on publicly available information

Florent Peron


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MHMarcel Hibert
Marcel Hibert
QZQian Zhao
Qian Zhao
LNLudovik Noël-Duchesneau
Ludovik Noël-Duchesneau
FPFlorent Peron
Florent Peron
ABAgathe Brugoux
Agathe Brugoux
JBJérôme Becker
Jérôme Becker
Oxytocin (OT) and its receptor (OT-R) are implicated in the aetiology of autism spectrum disorders (ASDs) and OT-R is a potential target for therapeutic intervention. We report here the design and pharmacological activity of a second-generation OT-R agonist that is more potent and selective than OT itself both in vitro and in vivo, in two animal models of autism after peripheral and oral administration. The preclinical potential of this new lead compound, LIT-002, is also evaluated and discussed.